Disopyramide
Disopyramide has electrophysiological actions similar to those of quinidine and procainamide but exerts greater anticholinergic effects than either, without antiadrenergic effects. Disopyramide has prominent negative inotropic effects, and patients who have evidence of abnormal ventricular function should receive the drug either not at all or only with extreme caution.
The role of disopyramide in the treatment of atrial and ventricular arrhythmias is similar to that of quinidine. Like quinidine, it can cause a 1:1 conduction during atrial flutter if the patient is not adequately digitalized. Disopyramide does not alter digitalis metabolism.
- Clinical Manifestations
- CLASSIFICATION OF THE MALABSORPTION SYNDROMES
- Sodium Retention
- DIAGNOSTIC TECHNIQUES AND THEIR INDICATIONS - IMAGING PROCEDURES
- Etiology and Pathogenesis
- Initial Assessment
- Plain Radiographs and Barium Contrast Studies
- DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
- Systemic Lupus Erythematosus (SLE)
- NONPHARMACOLOGICAL THERAPY OF TACHYARRHYTHMIAS
- MOTOR DISORDERS OF THE ESOPHAGUS
- PULMONARY HEART DISEASE
- PERIPHERAL ANEURYSMS AMD FISTULAE
- ANTIBIOTICS
- CARDIAC DEVELOPMENT
- TRAMSPLATTTATION
- LIVER BIOPSY
- Focal Glomerular Sclerosis (FQS)
- CARDIAC PACEMAKERS
- ETIOLOGY
- Lower GI Bleeding
- SPECIFIC MANIFESTATIONS OF RENAL DISEASE
- APPROACH TO THE PATIENT WITH SUSPECTED OR CONFIRMED ARRHYTHMIAS
- GENERAL MANAGEMENT OF MYOCARDIAL INFARCTION
- CIRCULATORY PHYSIOLOGY
- ENDOSCOPIC PROCEDURES
- CLINICAL TESTS OF DIGESTION AND ABSORPTION
- DIFFUSE INFILTRATIVE DISEASES OF THE LUNG
- PERICARDIAL EFFUSIOH
- ACUTE AND CHRONIC HEPATITIS - DEFIRILTIORI
- EFFECTS OF PULMONARY HYPERTENSION ON PULMONARY FUNCTION
- ACID-PEPTIC DISEASE
- SMOKE INHALATION
- Hepatic Encephalopathy
- CONSTRICTIVE PERICARDITIS